Rene Hemsey, Executive Vice President and Chief HR Officer of Church & Dwight Co Inc /DE/ (NYSE:CHD), filed a Form 4 on August 26, 2026, reporting a stock option exercise and same-day sale of common stock transacted on August 25, 2026.
Richard K. Laws, Senior Executive Vice President and Chief Legal Counsel of WesBanco Inc, filed a Form 4 on August 26, 2026, reporting a disposition of 1,558 shares of WesBanco common stock at $42.21 per share through a tax-withholding transaction.
Generate Biomedicines, Inc. filed a current report on Form 8-K on August 25, 2026, disclosing that draft copies of three clinical trial posters accepted for presentation at the European Respiratory Society Congress 2026 were inadvertently made publicly available via the ERS website before the …
A Form 4 filed on August 26, 2026, discloses that Denissa Rodriguez Adorno, Senior VP and Comptroller of Popular, Inc. (NASDAQ:BPOP), sold 600 shares of common stock on August 24, 2026, at a weighted average price of $168.786 per share.
A Form 4 filed on August 26, 2026 with the U.S. Securities and Exchange Commission reports that Brian J. Rosin, CFO of IM8 (US) LLC, purchased a combined 23,100 Class A Ordinary Shares of Prenetics Global Ltd across two open-market transactions on August 24 …
News Corporation filed a Form 8-K with the SEC on August 26, 2026, reporting its obligation to disclose daily stock repurchase transactions to the Australian Securities Exchange under its previously authorized $1 billion share buyback program.
Charter Communications, Inc. filed a current report on Form 8-K on August 26, 2026, disclosing the execution of four supplemental indentures and related guarantee arrangements entered into on August 24, 2026, following the completed acquisition of certain Cox Communications businesses.
Boston Scientific Corporation filed an 8-K current report with the SEC on August 26, 2026, disclosing a cybersecurity incident detected on August 25, 2026, that has caused a global disruption to the company's operations.
Western Digital Corporation filed a Form 8-K on August 26, 2026, disclosing privately negotiated exchange agreements covering approximately $191.0 million in aggregate principal amount of its 3.00% Convertible Senior Notes due 2028.
BeOne Medicines Ltd. filed a Current Report on Form 8-K on August 26, 2026, disclosing the submission of its 2026 Interim Report for the six months ended June 30, 2026 to the Science and Technology Innovation Board of the Shanghai Stock Exchange.